Dudediligence.

BioStem Technologies, Inc

BSEMNASDAQ
Write an idea

Price

From the filings

Figures

Revenue
$47.5Mlast 12 months
Net income
−$6.6Mlast 12 months
Operating cash flow
$9.9Mlast 12 months
Cash and equivalents
$7.0Mat the last balance sheet
Total debt
$0.00at the last balance sheet
Shares outstanding
17.8M shareson issue
Every year and quarter →